NAPA

NSF attachment protein alpha

Basic information

Region (hg38): 19:47487637-47515091

Links

ENSG00000105402NCBI:8775OMIM:603215HGNC:7641Uniprot:P54920AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NAPA gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NAPA gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
22
clinvar
22
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 22 1 0

Variants in NAPA

This is a list of pathogenic ClinVar variants found in the NAPA region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-47488299-C-T not specified Uncertain significance (Mar 06, 2025)3877618
19-47488343-G-A not specified Uncertain significance (Oct 04, 2024)3402649
19-47488364-C-T not specified Uncertain significance (Dec 09, 2023)3175122
19-47490808-G-A not specified Uncertain significance (Jan 03, 2024)3175121
19-47490820-A-G not specified Uncertain significance (Dec 13, 2022)2223276
19-47492052-G-C not specified Uncertain significance (Dec 10, 2024)3402650
19-47492063-G-T not specified Uncertain significance (May 27, 2022)2227305
19-47492073-T-C not specified Uncertain significance (Jul 20, 2021)2238372
19-47492077-C-T not specified Uncertain significance (Mar 03, 2025)3877619
19-47492089-G-A not specified Uncertain significance (Nov 16, 2024)3402647
19-47492098-T-G not specified Uncertain significance (Aug 08, 2022)2305453
19-47492101-C-T not specified Uncertain significance (Jan 29, 2025)3877617
19-47493008-C-T not specified Uncertain significance (Aug 04, 2023)2616376
19-47493448-T-G not specified Uncertain significance (Aug 28, 2024)3402645
19-47493465-T-C not specified Uncertain significance (Sep 22, 2023)3175115
19-47493489-C-T not specified Uncertain significance (Oct 03, 2024)3402648
19-47495551-A-G not specified Uncertain significance (Dec 20, 2023)3175112
19-47495560-T-C not specified Uncertain significance (Oct 17, 2023)3175109
19-47495570-T-C not specified Uncertain significance (Dec 19, 2022)2337614
19-47500642-C-T not specified Uncertain significance (Jul 27, 2024)3402646
19-47500657-C-T not specified Uncertain significance (Dec 20, 2023)3175101
19-47500667-G-A Likely benign (Mar 01, 2023)2650155
19-47500726-C-A not specified Uncertain significance (Apr 20, 2023)2539671
19-47500738-C-T not specified Uncertain significance (Dec 06, 2022)2333696
19-47503450-T-C not specified Uncertain significance (Mar 01, 2023)2492318

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NAPAprotein_codingprotein_codingENST00000263354 1127604
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.2400.7601257310171257480.0000676
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.9931421790.7910.00001051957
Missense in Polyphen3447.8140.71109513
Synonymous-0.3478177.11.050.00000567514
Loss of Function3.17520.50.2449.56e-7237

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001520.000152
Ashkenazi Jewish0.000.00
East Asian0.0001090.000109
Finnish0.000.00
European (Non-Finnish)0.00006190.0000615
Middle Eastern0.0001090.000109
South Asian0.0001700.000163
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Required for vesicular transport between the endoplasmic reticulum and the Golgi apparatus (Probable). Together with GNA12 promotes CDH5 localization to plasma membrane (PubMed:15980433). {ECO:0000269|PubMed:15980433, ECO:0000305}.;
Pathway
Synaptic vesicle cycle - Homo sapiens (human);Synaptic Vesicle Pathway;Golgi Associated Vesicle Biogenesis;Clathrin derived vesicle budding;trans-Golgi Network Vesicle Budding;Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;COPI-dependent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;Intra-Golgi traffic;COPI-mediated anterograde transport;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport;Retrograde transport at the Trans-Golgi-Network;Intra-Golgi and retrograde Golgi-to-ER traffic (Consensus)

Recessive Scores

pRec
0.130

Intolerance Scores

loftool
0.412
rvis_EVS
-0.03
rvis_percentile_EVS
51.66

Haploinsufficiency Scores

pHI
0.528
hipred
Y
hipred_score
0.739
ghis
0.569

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.971

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Napa
Phenotype
craniofacial phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
intracellular protein transport;endoplasmic reticulum to Golgi vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;intra-Golgi vesicle-mediated transport;brain development;regulation of synaptic vesicle priming;synaptic vesicle priming;neuron differentiation;positive regulation of ATPase activity;synaptic transmission, glutamatergic;SNARE complex disassembly;apical protein localization;COPII vesicle coating;membrane fusion
Cellular component
Golgi membrane;vacuolar membrane;cytosol;plasma membrane;membrane;SNARE complex;myelin sheath;synaptobrevin 2-SNAP-25-syntaxin-1a complex;extracellular exosome;presynapse;postsynapse;glutamatergic synapse
Molecular function
SNARE binding;soluble NSF attachment protein activity;protein binding;syntaxin binding;protein-containing complex binding